Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated Diarrhea (ADVENT)
This study is currently recruiting participants.
Study NCT00547898   Information provided by Salix Pharmaceuticals
First Received: October 21, 2007   Last Updated: November 22, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Associated Diarrhea
Additional conditions recognized in this trial
Diarrhea
More general conditions related to this trial
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
Placebo
Crofelemer 125 mg
Crofelemer 250 mg
Crofelemer 500 mg
Sponsors listed in this trial
Salix Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services